Search research articles
Contact Us
Filters
Showing results (541-550 of 588) with videos related to
Page
of 59
Sort By:
Cancer Discovery
|
April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockade
Xianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
A spatially resolved single cell genomic atlas of the adult human breast
Tapsi Kumar, Kevin Nee, Runmin Wei, et al.
Nature Communications
|
June 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma
Lauren P Cobb, Yibo Dai, Max Molina Ayala, et al.
The Journal of Clinical Investigation
|
March 26, 2011
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression
Lukas D Wartman, David E Larson, Zhifu Xiang, et al.
Cancer Cell
|
August 22, 2025
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
Alexander Biederstädt, Rafet Basar, Jeong-Min Park, et al.
Cancer Cell
|
August 13, 2024
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
Mayra Shanley, May Daher, Jinzhuang Dou, et al.
Nature Medicine
|
January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trial
David Marin, Ye Li, Rafet Basar, et al.
Journal of Clinical Psychopharmacology
|
April 6, 2022
Dosing of Mood Stabilizers for Bipolar Disorder Patients in the Research on Asian Psychotropic Prescription Patterns Consortium Study
Yuxi Wang, Qian Hui Chew, Shih-Ku Lin, et al.
Journal of Clinical Psychopharmacology
|
January 17, 2024
Pharmacoepidemiology and Clinical Correlates of Lithium Treatment for Bipolar Disorder in Asia
Yao Kang Shuy, Sanjana Santharan, Qian Hui Chew, et al.
JAMA
|
April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML
Daniel C Link, Laura G Schuettpelz, Dong Shen, et al.
Page
of 59
Search research articles
Search
Showing results (541-550 of 588) with videos related to
Sort By:
Page
of 59
Cancer Discovery
|
April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockade
Xianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
A spatially resolved single cell genomic atlas of the adult human breast
Tapsi Kumar, Kevin Nee, Runmin Wei, et al.
Nature Communications
|
June 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma
Lauren P Cobb, Yibo Dai, Max Molina Ayala, et al.
The Journal of Clinical Investigation
|
March 26, 2011
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression
Lukas D Wartman, David E Larson, Zhifu Xiang, et al.
Cancer Cell
|
August 22, 2025
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
Alexander Biederstädt, Rafet Basar, Jeong-Min Park, et al.
Cancer Cell
|
August 13, 2024
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
Mayra Shanley, May Daher, Jinzhuang Dou, et al.
Nature Medicine
|
January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trial
David Marin, Ye Li, Rafet Basar, et al.
Journal of Clinical Psychopharmacology
|
April 6, 2022
Dosing of Mood Stabilizers for Bipolar Disorder Patients in the Research on Asian Psychotropic Prescription Patterns Consortium Study
Yuxi Wang, Qian Hui Chew, Shih-Ku Lin, et al.
Journal of Clinical Psychopharmacology
|
January 17, 2024
Pharmacoepidemiology and Clinical Correlates of Lithium Treatment for Bipolar Disorder in Asia
Yao Kang Shuy, Sanjana Santharan, Qian Hui Chew, et al.
JAMA
|
April 21, 2011
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML
Daniel C Link, Laura G Schuettpelz, Dong Shen, et al.
Page
of 59